No information
No information is present at this moment.
No information is present at this moment.
| Oncological conditions |
|---|
|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Convulsions, often with hypertension and in a few cases followed by coma, paralytic ileus (particularly in young children), hepato-occlusive conditions
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Extravasation: Inject hyaluronidase into the area immediately. Cover the site of the extravasation with warm compresses. Consult the cosmetic surgeon.
General cytostatic agents: a range of cytostatics can trigger hypersensitivity reactions. An emergency set (containing epinephrine, clemastine and hydrocortisone) should be present in the treatment room. The emergency set also contains specific antidotes.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Vinca alkaloids and analogues | ||
|---|---|---|
| L01CA01 | ||
| Podophyllotoxin derivatives | ||
|---|---|---|
| L01CB01 | ||